What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?

被引：7
|
作者：
Dickstein, K [1 ]
机构：
[1] Univ Bergen, Cent Hosp Rogaland, Stavanger, Norway
来源：
AMERICAN HEART JOURNAL | 2003年 / 145卷 / 05期
关键词：
ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; HEART-FAILURE; MORTALITY; MORBIDITY; LOSARTAN; CAPTOPRIL; VALSARTAN; SURVIVAL;
D O I：
10.1016/S0002-8703(03)00168-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：754 / 757
页数：4
相关论文
共 50 条
  • [41] Surgical recommendations in the era of personalized medicine: What can we learn from patient preferences?
    Sullivan, Stephanie A.
    Temkin, Sarah M.
    CANCER, 2019, 125 (24) : 4367 - 4370
  • [42] What can we learn from physical capacity about biological age? A systematic review
    Tzemah-Shahar, Roy
    Hochner, Hagit
    Iktilat, Khalil
    Agmon, Maayan
    AGEING RESEARCH REVIEWS, 2022, 77
  • [43] The impact of exacerbations among subjects with COPD, what can we learn from 'big data'?
    Lindberg, Anne
    Bakke, Per S.
    Virchow, Johann Christian
    Lundback, Bo
    RESPIRATORY MEDICINE, 2018, 145 : 226 - 227
  • [44] The use of aortic counterpulsation in United States: What can we learn from administrative databases?
    McDonough, Ryan
    Ohman, E. Magnus
    AMERICAN HEART JOURNAL, 2014, 168 (03) : 237 - 238
  • [45] What can medicine expect from health economics?
    Bismarck, E.
    Schmitz-Draeger, B. J.
    Schoeffski, O.
    UROLOGE, 2012, 51 (04): : 533 - 538
  • [46] What Did We Learn in 2010 from the Phase III Trials? Is Maintenance Therapy the New Standard for Myeloma?
    Giralt, Sergio
    Stadtmauer, Edward
    McCarthy, Phillip
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : S30 - S32
  • [47] What We Learn From Exercise The Intersection of Diastolic and Renal Dysfunction
    Thomas, James D.
    Gong, Fei Fei
    JACC-CARDIOVASCULAR IMAGING, 2020, 13 (12) : 2495 - 2497
  • [48] Tight glycemic control: what do we really know, and what should we expect?
    Nasraway, Stanley A., Jr.
    Rattan, Rishi
    CRITICAL CARE, 2010, 14 (05):
  • [49] As nature did not predict dialysis-what we can learn from FGF23 in end-stage renal disease?
    Ketteler, Markus
    Biggar, Patrick H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) : 2618 - 2620
  • [50] Five decades of Fontan palliation: What have we learned? What should we expect?
    Hassan, Adil
    Chegondi, Madhuradhar
    Porayette, Prashob
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (10)
12345